Aurobindo Pharma gets US FDA nod for Bristol's Videx generic

New Delhi, Sept 25 (UNI) Aurobindo Pharma Ltd today said it has received the US Food and Drug Administration (USFDA) approval to sell the generic version of Bristol-Myers Squibb's Videx EC, which is used to treat HIV infection in adults.

With the USFDA nod, the drug maker can sell didanosine delayed release capsule in multiple strengths in the United States, it said in a statement.

UNI AK SG AS1545